"Outcomes of Tracheostomy Done for Patients Admitted in Anesthesia Intensive Care Units of Assiut University Hospital"
Launched by ASSIUT UNIVERSITY · Feb 10, 2018
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
Tracheostomy is described as the creation of a stoma at the skin surface which leads into the trachea. From the first tracheostomy until about 1930, the operation was performed exclusively for laryngeal obstruction. Nowadays, due to the development of the care of critically ill patients in intensive care units (ICUs), there are other indications for the procedure including prolonged intubation and pulmonary toilet.
The initial management of patients in an intensive care unit involves a series of interventions that aim to stabilize and then optimize their physiological state. Mechanical ven...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients who were admitted to the ICUs of the main Assiut University Hospital.
- • mechanically ventilated and
- • underwent tracheostomy during his/her stay in ICU.
- Exclusion Criteria:
- • Patients who were admitted to ICUs and didn't need tracheostomy during the period of admission in ICU or after discharge from ICU,
- • Patients who died during admission in ICUs before being tracheostomized,
- • Patients who died during admission in ICUs after being tracheostomized and the cause of death was not related to the tracheostomy procedure or care.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Assiut Governorate, Egypt
Patients applied
Trial Officials
Hala S Abdelghaffar, MD
Principal Investigator
Professor in anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials